AI-powered
Pilot study evaluating different methods of circulating tumor DNA quantification in radiation oncology patients
Study on Detecting Cancer DNA in Blood and Urine
Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
This study aims to invent a test that can see tiny pieces from your cancer (specifically DNA from your cancer) in blood and urine better than tests that can currently be done. In the future, this test can possibly be used to find a small cancer before other tests can find it.
Detailed description of study
This pilot study aims to obtain preliminary data for exploratory comparisons of different ctDNA detection approaches.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cancer
-
Age: 18 years - 100 years
-
Gender: All
Inclusion Criteria
Plan to undergo radiation therapy
Exclusion Criteria
Dialysis dependent
Updated on
19 Feb 2024.
Study ID: 1808165247 (IUSCC-0669)
This study investigates a new test that aims to detect small pieces of cancer DNA in blood and urine. Cancer DNA, or ctDNA, refers to the genetic material released by cancer cells into the bloodstream. This study looks to improve the detection of ctDNA compared to current methods.
Participants in the study will undergo different procedures to compare ctDNA detection approaches. The study will collect data on how well these methods work in identifying cancer DNA from blood and urine samples.
- Who can participate: Adults who plan to undergo radiation therapy can participate. Individuals who are dependent on dialysis are not eligible.
- Study details: Participants will provide blood and urine samples for the study. These samples will be used to test different methods of detecting cancer DNA, also known as circulating tumor DNA (ctDNA).